NCT02702323 Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study Status UNKNOWN Phase PHASE2/PHASE3
NCT02693847 Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients Status COMPLETED Phase N/A
NCT02686372 A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation Status COMPLETED Phase PHASE1
NCT02683538 Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies Status COMPLETED Phase PHASE2
NCT02678806 Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion Status UNKNOWN Phase NA
NCT02670122 Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC Status COMPLETED Phase N/A
NCT02658019 Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02649712 Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction Status COMPLETED Phase NA
NCT02642913 Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients Status COMPLETED Phase PHASE1
NCT02626312 Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function Status TERMINATED Phase PHASE1
NCT02616926 Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT02595866 Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Status COMPLETED Phase PHASE1
NCT02587884 Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH Status UNKNOWN Phase PHASE1
NCT02587793 Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients Status COMPLETED Phase N/A
NCT02587689 Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2